2. Natural Products
  3. Plants
  4. Compositae
  5. Carpesium cernuum L.

Carpesium cernuum L.

Carpesium cernuum L. (7):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N0398
    Sec-O-Glucosylhamaudol 80681-44-3 99.81%
    Sec-O-Glucosylhamaudol is a natural compound extracted from Peucedanum japonicum Thunb, decreases levels of μ-opioid receptor, with analgesic effect.
    Sec-O-Glucosylhamaudol
  • HY-122958
    Peucedanocoumarin III 130464-57-2
    Peucedanocoumarin III is an inhibitor of (alpha)-synuclein and Huntington protein aggregates that enhances the clearance of nuclear and cytoplasmic β23 aggregates and prevents cytotoxicity induced by disease-associated proteins (i.e., mutant Huntington proteins and α-synuclein). Peucedanocoumarin III may be used in Parkinson's disease research.
    Peucedanocoumarin III
  • HY-N1597
    (19Z)-Normacusine B 124096-81-7
    (19Z)-Normacusine B, Gelsemiurn alkaloids, is a natural product that can be isolated from Gelsemiurn.
    (19Z)-Normacusine B
  • HY-N3090
    Peucedanol 46992-81-8
    Peucedanol is a non-competitive inhibitor of CYP3A4 with a Ki value of 4.07 μM and a competitive inhibitor of CYP1A2 and CYP2D6 with Ki values of 3.39 μM and 6.77 μM, respectively.
    Peucedanol
  • HY-N9017
    12E,14-Labdadien-20,8β-olide 1639257-37-6
    12E,14-Labdadien-20,8β-olide, a labdane diterpenoid, is a natural product that can be isolated from the rhizomes of Isodon yuennanensis.
    12E,14-Labdadien-20,8β-olide
  • HY-N0398R
    Sec-O-Glucosylhamaudol (Standard) 80681-44-3
    Sec-O-Glucosylhamaudol (Standard) is the analytical standard of Sec-O-Glucosylhamaudol. This product is intended for research and analytical applications. Sec-O-Glucosylhamaudol is a natural compound extracted from Peucedanum japonicum Thunb, decreases levels of μ-opioid receptor, with analgesic effect.
    Sec-O-Glucosylhamaudol (Standard)
  • HY-N13294
    Cernuumolide J 2019163-02-9
    Cernuumolide J (TMJ-105) is an JAK2/STAT3 inhibitor. Cernuumolide J induces G2/M phase arrest and apoptosis in HEL leukemia cells by downregulating the phosphorylation of JAK2, STAT3, and Erk, and activating the phosphorylation of JNK and p38 MAPK. Cernuumolide J inhibits HEL leukemia cell growth in a time- and concentration-dependent manner, with an IC50 value of 1.79 μM. Cernuumolide J can be used for research in the field of anti-cancer therapy.
    Cernuumolide J